KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression

Despite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1, promotes podocyte injury in vitr...

Full description

Bibliographic Details
Main Authors: Kristin Meliambro, Yanfeng Yang, Marina de Cos, Estefania Rodriguez Ballestas, Caroline Malkin, Jonathan Haydak, John R. Lee, Fadi Salem, Laura H. Mariani, Ronald E. Gordon, John M. Basgen, Huei Hsun Wen, Jia Fu, Evren U. Azeloglu, John Cijiang He, Jenny S. Wong, Kirk N. Campbell
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-04-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.165002
_version_ 1797634287699230720
author Kristin Meliambro
Yanfeng Yang
Marina de Cos
Estefania Rodriguez Ballestas
Caroline Malkin
Jonathan Haydak
John R. Lee
Fadi Salem
Laura H. Mariani
Ronald E. Gordon
John M. Basgen
Huei Hsun Wen
Jia Fu
Evren U. Azeloglu
John Cijiang He
Jenny S. Wong
Kirk N. Campbell
author_facet Kristin Meliambro
Yanfeng Yang
Marina de Cos
Estefania Rodriguez Ballestas
Caroline Malkin
Jonathan Haydak
John R. Lee
Fadi Salem
Laura H. Mariani
Ronald E. Gordon
John M. Basgen
Huei Hsun Wen
Jia Fu
Evren U. Azeloglu
John Cijiang He
Jenny S. Wong
Kirk N. Campbell
author_sort Kristin Meliambro
collection DOAJ
description Despite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1, promotes podocyte injury in vitro through activation of the Hippo signaling pathway. KIBRA expression is increased in the glomeruli of patients with focal segmental glomerulosclerosis, and KIBRA depletion in vivo is protective against acute podocyte injury. Here, we tested the consequences of transgenic podocyte-specific WWC1 expression in immortalized human podocytes and in mice, and we explored the association between glomerular WWC1 expression and glomerular disease progression. We found that KIBRA overexpression in immortalized human podocytes promoted cytoplasmic localization of Yes-associated protein (YAP), induced actin cytoskeletal reorganization, and altered focal adhesion expression and morphology. WWC1-transgenic (KIBRA-overexpressing) mice were more susceptible to acute and chronic glomerular injury, with evidence of YAP inhibition in vivo. Of clinical relevance, glomerular WWC1 expression negatively correlated with renal survival among patients with primary glomerular diseases. These findings highlight the importance of KIBRA/YAP signaling to the regulation of podocyte structural integrity and identify KIBRA-mediated injury as a potential target for podocyte-specific therapy in glomerular disease.
first_indexed 2024-03-11T12:06:29Z
format Article
id doaj.art-427bdc10103645eb8f284f1c9af46d1b
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:06:29Z
publishDate 2023-04-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-427bdc10103645eb8f284f1c9af46d1b2023-11-07T16:25:25ZengAmerican Society for Clinical investigationJCI Insight2379-37082023-04-0187KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progressionKristin MeliambroYanfeng YangMarina de CosEstefania Rodriguez BallestasCaroline MalkinJonathan HaydakJohn R. LeeFadi SalemLaura H. MarianiRonald E. GordonJohn M. BasgenHuei Hsun WenJia FuEvren U. AzelogluJohn Cijiang HeJenny S. WongKirk N. CampbellDespite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1, promotes podocyte injury in vitro through activation of the Hippo signaling pathway. KIBRA expression is increased in the glomeruli of patients with focal segmental glomerulosclerosis, and KIBRA depletion in vivo is protective against acute podocyte injury. Here, we tested the consequences of transgenic podocyte-specific WWC1 expression in immortalized human podocytes and in mice, and we explored the association between glomerular WWC1 expression and glomerular disease progression. We found that KIBRA overexpression in immortalized human podocytes promoted cytoplasmic localization of Yes-associated protein (YAP), induced actin cytoskeletal reorganization, and altered focal adhesion expression and morphology. WWC1-transgenic (KIBRA-overexpressing) mice were more susceptible to acute and chronic glomerular injury, with evidence of YAP inhibition in vivo. Of clinical relevance, glomerular WWC1 expression negatively correlated with renal survival among patients with primary glomerular diseases. These findings highlight the importance of KIBRA/YAP signaling to the regulation of podocyte structural integrity and identify KIBRA-mediated injury as a potential target for podocyte-specific therapy in glomerular disease.https://doi.org/10.1172/jci.insight.165002Cell biologyNephrology
spellingShingle Kristin Meliambro
Yanfeng Yang
Marina de Cos
Estefania Rodriguez Ballestas
Caroline Malkin
Jonathan Haydak
John R. Lee
Fadi Salem
Laura H. Mariani
Ronald E. Gordon
John M. Basgen
Huei Hsun Wen
Jia Fu
Evren U. Azeloglu
John Cijiang He
Jenny S. Wong
Kirk N. Campbell
KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
JCI Insight
Cell biology
Nephrology
title KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
title_full KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
title_fullStr KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
title_full_unstemmed KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
title_short KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
title_sort kibra upregulation increases susceptibility to podocyte injury and glomerular disease progression
topic Cell biology
Nephrology
url https://doi.org/10.1172/jci.insight.165002
work_keys_str_mv AT kristinmeliambro kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT yanfengyang kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT marinadecos kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT estefaniarodriguezballestas kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT carolinemalkin kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT jonathanhaydak kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT johnrlee kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT fadisalem kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT laurahmariani kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT ronaldegordon kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT johnmbasgen kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT hueihsunwen kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT jiafu kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT evrenuazeloglu kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT johncijianghe kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT jennyswong kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression
AT kirkncampbell kibraupregulationincreasessusceptibilitytopodocyteinjuryandglomerulardiseaseprogression